Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Provision of Optune Therapy

Imperial College Healthcare NHS Trust

This public procurement record has 2 releases in its history.

Award

27 Jul 2026 at 17:20

UK6 - Contract Award Notice
Award

27 Jul 2026 at 17:09

UK5 - Transparency Notice
Summary of the contracting process

Imperial College Healthcare NHS Trust procured Optune Therapy for private patients receiving brain tumour treatment at home. The requirement covers the supply of this specialist therapy and associated medical devices and products for home-based care in London. Central London Community Healthcare NHS Trust’s North West London Procurement Service managed the procurement for Imperial College Healthcare NHS Trust and other trusts across North West London. The therapy supports consultant-led neuro-oncology treatment pathways and private patient services, including care funded through insurers. This is a clinically specialised home-treatment requirement rather than a general medical equipment supply, so it is most relevant to organisations working in neuro-oncology, specialist medical devices, patient treatment support or home-based healthcare delivery.

The procurement has been awarded through a direct award to Novocure, with the award dated 27 July 2026. The stated basis was the absence of competition for technical reasons: Novocure owns and exclusively supplies the patented Optune technology, and the Trust identified no clinically equivalent alternative provider. The award value is £3.6 million excluding VAT and £4.32 million including VAT. The contract period is 7 August 2026 to 6 August 2027, with a maximum extent to 6 August 2028 and a 12-month extension that must be agreed in writing after internal governance. The award is for one completed lot. A future signature milestone was scheduled for 7 August 2026.

This award demonstrates demand for a proprietary, specialist therapy embedded in private neuro-oncology pathways. A competitor would need to offer a clinically equivalent treatment, or control the relevant intellectual property and supply route, to be credible for this specific requirement; the Trust expressly identified Novocure as the sole provider. Relevant operational capability includes clinical prescribing pathways, patient onboarding and training, home-based treatment delivery, treatment monitoring, governance, compliance and data management. Suppliers would also need to understand private healthcare funding arrangements and insurer reimbursement, including alignment with major insurers such as Bupa. The requirement highlights the importance of uninterrupted supply, continuity of care and integration with consultant-led treatment plans.

How relevant is this notice?

Notice Information

Notice Title

Provision of Optune Therapy

Notice Description

Provision of Optune Therapy for private patients receiving brain tumour treatment at home under Imperial College Healthcare NHS Trust.

Procurement Information

* Optune Therapy is a proprietary, patented technology owned and supplied exclusively by Novocure. * There are no clinically equivalent alternative suppliers offering TTFields-based therapy. * As a result, this procurement meets the criteria for single supplier award due to absence of competition for technical reasons. * There is no alternative provider capable of delivering equivalent treatment, and any disruption would compromise continuity of care. * Maintaining uninterrupted access is essential given the complexity and specialist nature of neuro-oncology pathways. * The Trust has a fully embedded delivery model in place with Novocure, including: o Clinical prescribing pathways o Patient onboarding and training o Home-based treatment delivery and monitoring o Governance, compliance, and data processes * Optune Therapy is recognised within private healthcare funding pathways, including alignment with major insurers (e.g. Bupa), supporting treatment reimbursement and patient access. * Maintaining availability of this therapy ensures: o Continuity of insurer-funded care pathways o Protection of existing revenue streams within private patient services o Alignment with consultant-led treatment plans

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-06d49e
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/070955-2026
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
UK6 - Contract Award Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Direct
Procurement Method Details
Direct award
Tender Suitability
SME, VCSE
Awardee Scale
SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33190000 - Miscellaneous medical devices and products

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
£3,600,000 £1M-£10M
Contracts Value
Not specified

Notice Dates

Publication Date
27 Jul 20262 months ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
27 Jul 20262 months ago
Contract Period
7 Aug 2026 - 6 Aug 2027 6-12 months
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Pending
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
Imperial College Healthcare NHS Trust
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
W2 1NY
Postcode Area
West London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI3 Inner London - West
Small Region (ITL 3)
TLI35 Westminster and City of London
Delivery Location
Not specified
Local Authority
Westminster
Electoral Ward
Hyde Park
Westminster Constituency
Cities of London and Westminster

Supplier Information

Number of Suppliers
1
Supplier Name

Novocure

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...